A carregar...

JAK2 Expression is Associated with Tumor-Infiltrating Lymphocytes and Improved Breast Cancer Outcomes: Implications for Evaluating JAK2 Inhibitors

Janus kinase-2 (JAK2) supports breast cancer growth and clinical trials testing JAK2 inhibitors are underway. In addition to the tumor epithelium, JAK2 is also expressed in other tissues including immune cells; whether the JAK2 mRNA levels in breast tumors correlate with outcomes has not been evalua...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Miller, Chris P., Thorpe, Jason D., Kortum, Amanda N., Coy, Catherine M., Cheng, Wei-Yi, Yang, Tai-Hsien Ou, Anastassiou, Dimitris, Beatty, J. David, Urban, Nicole D., Blau, C. Anthony
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4001121/
https://ncbi.nlm.nih.gov/pubmed/24764577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-13-0189
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!